Germany: Telemedicine regulation challenges amid market growth with new patient-focused products

Emergency judgments obtained by telemedicine pioneer DrAnsay.com: Court prohibits illegal practices and criminal offenses by cannabis providers.

• AKNR obtained a preliminary injunction against Cura medics for unauthorized advertising and violations of the German Medicines Advertising Act.
• North Rhine Chamber of Pharmacists prohibits cannabis advertising; claims remote treatment model is illegal and lacks professional standards.
• Munich court bans remote diagnosis for cannabis prescriptions, ruling it violates advertising laws and medical standards, posing risks of misuse.
• Frankfurt court ruled automatic pharmacy allocation is legal if patients choose the premium service, ensuring free choice of pharmacy.
• GMK urges federal government to amend cannabis prescription laws for mandatory personal consultations to enhance health protection and safety.
• Grünhorn CEO criticises health minister’s remarks on cannabis being an intoxicating drug, sizing patient needs and the importance of medical cannabis for chronic conditions.
  • CDU MP Christ calls cannabis legalization a mistake, urging repeal due to public health risks and unfulfilled promises on crime prevention. Warken’s comments on cannabis prescriptions spark criticism; Grünhorn CEO advocates for patient needs and highlights benefits of medical cannabis therapy.
  • Industry stakeholders are proposing over-the-counter sales of products with a moderate 10% THC content, serving as a starting point and building block for optimal patient care.
  • Germany faces legal challenges for OTC THC cannabis sales due to international drug laws and EU pharmaceutical regulations.
  • Federal Court of Justice confirms 7.5g THC limit for “non-insignificant quantity” despite criticism and potential legal challenges.
  • Prisoners can now possess up to 50 grams of cannabis in their cells under new legal interpretations of cannabis laws.
• Sanaleo becomes first German wholesaler to receive tax stamp for THC-free CBD flowers, subject to tobacco tax and VAT.
  • A proposed EU classification could label CBD as a reproductive toxicant, potentially banning its use in cosmetics and food, impacting its use in cosmetics and food, prompting industry concerns and regulatory scrutiny.
• Things are still not going well for cannabis cultivation associations – the so-called Cannabis Social Clubs (CSCs) – in Germany
  • 8.9% of cultivation associations in Rhineland-Palatinate have distributed cannabis; licensing process poses significant challenges for clubs.
  • Berlin cannabis clubs face bureaucratic delays; only one club distributes legally, while alternatives offer faster access to cannabis.
  • Kirchdorf cannabis club’s cultivation was abruptly halted by authorities, requiring a building permit despite prior exemptions and approvals.
  • Franken.Cannabis Club in Bavaria receives cultivation license, allowing indoor and outdoor growth, with high demand for membership and varieties among its 25 members.
  • NoTill420 Cannabis Club focuses on sustainable cultivation, has 40 members, and operates four flowering rooms in the Westerwald region.
  • Cannabis project in Aschheim failed due to lack of approval; entrepreneur faces financial issues and plans to continue smaller ventures.

Germany imported over 37 tons of medical cannabis flower in Q1 2025, surpassing the previous record of 32 tons in Q4 2024. German medical cannabis market growing; potential patients estimated at 1.3 to 1.7 million by 2026 after partial legalization. The fact that legal cannabis in Germany is more affordable than the ilicit market is driving momentum.

• However, Cannabis consumption among Frankfurt youth has declined, with only 22% having tried it, indicating effective prevention efforts.
• Cannabis use among seniors for pain relief increased to 7% of consumer quota, despite limited medical data and uncertain risks.
• Mary Jane becomes the world’s largest cannabis trade fair with 60,000 visitors.
• Curaleaf International and Jupiter Research secured EU certification for the first handheld liquid inhalation device for medical cannabis use.
• Cantourage achieved a record revenue of EUR 11.1 million in April 2025, surpassing its previous record from March 2025.
• DEMECAN launches first fresh extract using Live Rosin process in Germany, enhancing medical cannabis quality and innovation standards.
• Grünhorn’s Medicinal cannabis cream for chronic skin diseases now available by prescription, targeting neurodermatitis, psoriasis, and eczema relief.
  • Canymed partners with Maximilian Pollux to educate on medical cannabis and reduce stigma through a podcast series and public awareness.
• SOMAÍ Pharmaceuticals launched the Senses product line of oral extract solutions in the German market, featuring terpene-enriched formulations.
• CannaPharmaRX completed shipments to Germany and Israel, with plans for more shipments and increased cultivation capacity in 2025.

 Ekocan report critiques cannabis legalization effects in North America; predicts different outcomes for Germany‘s non-profit model and consumer behavior.

• Federal Office for Agriculture and Food (BLE) rejected a cannabis pilot project application, citing concerns over distribution and compliance with existing regulations, prompting criticism from VierZwanzig.

United States landscape: California’s regulatory upheaval threatens jobs, while hemp thrives and companies pivot to international markets

 California proposes a permanent ban on hemp THC, risking 18,000 jobs and billions in revenue, amid public health concerns.

• Governor Newsom cites public health risks and competition concerns from unregulated hemp products as reasons for the ban. Estimated economic impact includes $602 million revenue loss in the first year and $3.14 billion over five years.
• California proposes limiting THC in animal cannabis products to 1 milligram of THC, prompting veterinarians to warn it could endanger pets’ health and safety. Veterinarians argue this policy could lead pet owners to use human products, posing risks to animal health.
• U.S. cannabis companies export illegally while MMJ BioPharma faces bureaucratic delays, highlighting a federal double standard in enforcement.
  • Incoming DEA Administrator Terrance Cole must decide between restoring scientific integrity or continuing selective enforcement against compliant companies.
• Texas Governor Greg Abbott vetoed a bill that would have banned hemp-derived THC products, supporting the industry instead.
  • Abbott expanded Texas’s medical marijuana program, allowing more THC per dose and increasing the number of dispensaries. Texas became the 40th U.S. state to legalize medical marijuana, improving access for patients with chronic conditions.

U.S. hemp production value increased 40% in 2024, reaching $445 million, driven by a surge in floral hemp acreage.

• Pre-rolls dominate cannabis market, with infused varieties leading growth, automation standardizing production, and brand loyalty driving competition. Pre-roll market projected to reach $3.1 billion, with 316.8 million units sold and 12% year-over-year growth.
  • Missouri brands excel in national pre-roll sales, with Proper Cannabis, Illicit Gardens, and Elevate among top performers.
• Fast-acting cannabis gummies are gaining popularity, commanding premium prices and outperforming traditional edibles in sales and consumer interest.
  • Wyld launches a new Kiwi THC:THCV gummy, introducing energizing effects and expanding its product lineup to 15 SKUs.
• California‘s legal cannabis market faces historic sales drop, with taxable sales at $1.088 billion, an 11% decline from last year. California marijuana consumers aren’t buying less product at state-licensed stores, but they do appear to be buying cheaper ones.
  • Upcoming tax increase from 15% to 19% expected to further contract the market, with proposed law to block it. Legal market struggles due to high fees, taxes, and competition from illegal cannabis stores, supplying only 38% of consumption.
  • California cannabis licenses, once valued at millions, are now nearly worthless due to market saturation and competition from illegal sales.
    • California’s cannabis industry also faced job losses, shedding 3,995 jobs, or 5% of its workforce last year.
      • Arizona‘s legal cannabis jobs dropped over 50%, from 20,000 to 10,000, amid declining sales and economic struggles.
  • CBN’s popularity in California’s cannabis market surged, becoming key in top-selling edibles, promoting sleep, and increasing market share significantly.
    • Papa Medical sets terms for $5 million IPO, plans to offer 1.3 million shares at $4, targeting $85 million valuation.
    • Josh Kesselman from RAW papers buys High Times for $3.5 million, plans $1.85 million investment to revive the magazine’s legacy and community focus.
    • Glass House Brands and LEEF Brands announced a management services agreement for The Leaf El Paseo dispensary in California.
• Cannabis companies are expanding into Europe, anticipating a $50 billion market due to favorable regulations and growth potential. Still, U.S. market shows clear and ongoing development;
  • Philip Morris invests in medical cannabis, focusing on partnerships with Aurora Cannabis and Avicanna for product development and research.
  • The Cannabist Company launched COAST Cannabis Co. edibles in Maryland, offering premium gummies for adult-use consumers and medical patients.
  • Xebra Brands partners with NF Skin to launch ELEMENTS™ CBD product line in the U.S. by summer 2025.
  • LEEF Brands reports Q1 2025 revenue growth expands production, enters New York market, and plants Salisbury Canyon Ranch for future growth.
  • Thomas Winstanley, Executive VP for Edibles.com, explains how the company plans to increase consumer confidence in hemp-derived THC products.
•  

Cannabis use is rising in the U.S., with increased prevalence of cannabis use disorder linked to higher consumption rates and potency. With 12% of adults using cannabis in the past month as of 2022, cannabis use disorder (CUD) affects approximately 17% of cannabis users, with higher prevalence among frequent users.

• Study reveals water activity significantly influences cannabis smoke quality, cannabinoid delivery, and consumer experience, impacting product safety and profitability, and highlights economic impact of water activity management, revealing potential revenue loss due to moisture content variations in cannabis.
  • Study compares acute effects of vaporized delta-8-THC and delta-9-THC in healthy adults, addressing gaps in previous research regarding to pharmacodynamics.
  • Study shows high cannabis use among veterans aged 65-84, with significant rates of cannabis use disorder and need for health screenings.
  • Study investigates how different cannabis administration methods affect THC levels and subjective effects among regular users.
  • Cannabis use affects driving performance; occasional users showed increased lane departures, while daily users had minimal performance changes.
• Research on cannabis genetics focuses on genetic bottlenecking and its impact on diversity and medicinal potential.
• Protagenic Therapeutics and Phytanix combine to form a new biopharmaceutical company with six drug candidates targeting obesity and metabolic disorders.

 Australia: Regulatory crackdown and industry growth amid prescription concerns and market innovations

The Australian Medical Association is supporting a crackdown on exploitation of schemes allowing medical cannabis prescriptions.

• New data has revealed alarming practices in the prescribing of medicinal cannabis, with one doctor appearing to issue a script every 4 minutes. AMA supports TGA’s legislative proposal to share information on unapproved therapeutic goods and address SAS and APS exploitation.
  • AHPRA is aware of eight doctors writing 80,000 cannabis prescriptions.
  • The health regulator has launched legal action against four firms and a company director over allegations they advertised medicinal cannabis
• To protect the industry from foreign imports, a new cannabis cultivation lobbying group has formed in Australia and called for “urgent action” to “save the local industry from collapse”.
  • Australian farmers are warning of “catastrophic failures” in the medicinal cannabis industry if the government does not reduce its reliance on international imports.
• The Australian Pesticides and Veterinary Medicines Authority has updated its position on the registration of hemp-based animal products. New South Wales impact of the regulatory framework for cannabis
• A parliamentary inquiry in NSW overwhelmingly backed decriminalisation and eventual legalisation, calling the current system discriminatory: those who can afford medicinal cannabis avoid prison, while others face up to two years’ jail.
  • NSW’s Legislative Council committee urges repealing prison terms for small possessions and expanding the local medicinal cannabis industry.

More than 113,000 SAS-B applications were approved by the TGA between January and June, a 27% increase on the same period last year. At the current rate, 2025 is set to eclipse 200,000 approvals by year’s end, easily beating last year’s record of 177,762.

• Curaleaf International launches medical cannabis products in Australia, with four flower strains distributed via Canngea. Future products will include precision-dosed inhalation formats and popular strains already prescribed in Europe.
• Providing existing customers with a consistent supply of quality cannabis must take priority over winning new contracts, ECS has said. ECS Botanics expects a 50% increase in FY25 production, exceeding 9.8 tonnes with lower production costs, aiming for positive cash flow in 2025.
  • ECS Botanics launches Terphogz™ cannabis product range in Australia, enhancing its premium portfolio and B2C distribution strategy.
• THC beverages manufacturer Althea Group has sold its pharma subsidiary to a medicinal cannabis producer Tasmanian Botanics to focus on US expansion.
• Creditors of Releaf Group unlikely to receive payment due to lack of new information on the company’s collapse.
• Vitura Health-Crisci Group JV Flora Holdings acquires Heyday Medical clinic operations amid growing consolidation in the medicinal cannabis sector. The acquisition includes a 5,000-strong patient database.
• ANTG achieved its 100th crop milestone without failures as it expands its product portfolio, including high-THC strains like El Jefe, known as Rocky in Australia.
• Nectar Brands launches Australia’s first all-in-one vape, marking a significant innovation in the vaping market.
• Bioxyne posts 720% share price gain in 2024-25, making it the top performing ASX biotech.

Cold water immersion stress does not increase blood THC levels or induce intoxication in regular cannabis users.

• End-of-day far-red light can enhance cannabinoid concentration in medicinal cannabis without affecting flower biomass yields.
• Study investigates global cannabis use for endometriosis, highlighting motivations, barriers, and stigma affecting consumption and disclosure.
• Thesis on glandular trichome initiation and morphogenesis in Cannabis sativa submitted for Ph.D. at La Trobe University.
• NTI164 showed safety and improved clinical and functional outcomes in RTT, justifying further research as a potential adjunct therapy.

 Canada market matures with record financial performance despite regulatory headwinds and market saturation

The Cannabis Council of Canada and Deloitte issued a report calling for cannabis excise reform to help licensed producers thrive.

• Alberta’s new Cannabis Enforcement Unit seized 162 kg of cannabis intended for illegal online sales, arresting two BC residents.
• Ghost Drops speaks out against a quarter-million-dollar fine, asserting they are being made an example of in the cannabis sector.

Cannabis contribution to the Canadian GDP keeps climbing to $9.2B. The newest quarterly wholesale cannabis figures from the BCLDB show a 9% year on year growth in legal sales in Q1 2025 in British Columbia, slightly down vs Q4 20254 as the market slows down after six years of growth.

• Organigram reports record Q2 2025 results with 79% revenue increase, strong international sales, and successful Motif integration.
• Village Farms International is spinning off its fresh produce unit, which generated $169m in sales in 2024.
• SNDL reports record gross margin and positive cash flow; Announces strategic review of U.S. platform and listing structure.
• Canopy Growth launched new cannabis products targeting Canada’s adult-use market.
• Aurora Cannabis expands medical pricing program eligibility from $40,000 to $60,000 CAD, enhancing access for more patients in Canada.
• Avant Brands signed international supply agreements, expanded product offerings in Canada, and relaunched its medical division for growth.
• Decibel reports Q1 2025 revenue of $21.2 million, driven by AgMedica acquisition, with improved balance sheet and international sales growth.
• MediPharm Labs reports strong Q1 2025 results with 11% revenue growth and positive Adjusted EBITDA, driven by international cannabis sales. It also sold its Hope Facility for $4.5 million and is expanding cultivation capacity at its Napanee Facility by 30%.
• Rubicon Organics reported Q1 2025 revenue of $12.4 million, a 39.2% increase, and positive Adjusted EBITDA of $0.7 million.
• McIntyre Creek Cannabis proves outdoor cannabis can match or exceed greenhouse quality in ideal growing conditions in British Columbia.
• Freedom cannabis exits CCAA with a successful financial restructuring, ready to move forward with its business operations.
• Xebra Brands corrects press release, announces management cease trade order application, CFO resignation, and warrant expiration extension to December 2025.
• Canadian craft cannabis is in high demand internationally, especially from micro and craft growers in BC, amid evolving market trends.

**Identified 33 significant SNP**s markers linked to cannabinoid traits, including a massive haplotype on chromosome 7 in drug-type Cannabis.

• Tilray Medical published research comparing bioavailability of THC:CBD formulations, enhancing understanding of medical cannabis pharmacokinetics.
• Introduction of Mindful Consumption and Benefit Maximization (MCBM) for cannabis education focusing on consumer goals and harm reduction.
• Aurora Cannabis faces a class action for failing to warn about Cannabinoid Hyperemesis Syndrome risks linked to its products.

United Kingdom cannabis industry expands despite regulatory deadlock, as London pushes for decriminalisation

Report commissioned by the London city council recommends decriminalising cannabis possession, banning stop and search, and enhancing cannabis training for police forces.

• UK’s Mayor Sadiq Khan supports cannabis decriminalisation; independent commission recommends reclassification, but government opposes changes to drug laws.
• Cannabis seizures at UK airports reached record highs, primarily due to Thai gangs smuggling drugs into the country; despite Border Force claiming 90% drop in mail-order Thai cannabis.

 UK medical cannabis market growing rapidly, with Script Assist processing over 12,000 prescriptions monthly and improving operational efficiency significantly.

• Clinics report significant operational improvements, including reduced manual interventions and increased prescription processing efficiency. Market opportunity exists as patient numbers increase, with high-value patients spending approximately £2,000 annually and low churn rates.
  • Surge in medical cannabis products in UK, exceling in format diversity, as industry stakeholders claim potential to treat 500,000 patients in the UK within five years despite regulatory challenges.
• Glass Pharms partners with Mamedica to supply cannabis flower for clinician-prescribed products, enhancing UK’s domestic medical cannabis supply chain.
  • Cookies also partners with UK cannabis clinic Mamedica to launch medical products as Britain weighs cannabis reform and decriminalization.
• Dalgety, a UK-based EU-GMP certified medical cannabis cultivator, is pleased to announce a strategic partnership with Curaleaf Laboratories, a trusted name in cannabis medicine and pharmaceutical-quality cannabinoid innovation.
• MediPharm Labs launches cannabis metered dose inhalers in the EU and UK, partnering with Blackpoint for distribution and compliance.
  • The Bloom Brand, a recognized U.S. leader in cannabis vape, is making its international debut in the United Kingdom through a partnership with New Garden Pharma.
• New Industrial Hemp Innovations Hub launched at Aberystwyth University to promote sustainable hemp applications and support green economic growth.
  • JTI acquires controlling stake in Flavour Warehouse, UK’s largest independent vape company, to expand into the growing vape market.

France: moving toward creating a controlled framework for medical cannabis

The French government plans to grant full authorization for medical cannabis by 2026, following successful patient trials. Over 3,200 patients have participated in the cannabis experiment, showing improved quality of life and low adverse effects.

 Mao Aoust, the founder of High Society CBD shops, is charged with transporting and selling narcotics after police custody, due to the marketing of synthetic cannabinoids.

• High Society generates nearly 20 million euros annually, employing over 150 people, while allegedly supplying illegal synthetic cannabis to other shops. The arrest followed an investigation into poisoning cases among teenagers who consumed prohibited CBD products, initiated by a magistrate from Nîmes.
• France’s medical cannabis pilot program demonstrated safety and efficacy, with over 3,200 patients enrolled and high satisfaction rates. • Regulatory uncertainty and limited domestic supply chains impede market deployment; reforms are needed for local production and flexible product forms.

Cannabis and CBD use motives are correlated; therapeutic use is common among co-users, highlighting potential for harm reduction strategies.

• Four distinct profiles of cannabis-CBD co-users were identified based on their motives, including therapeutic and recreational orientations. CBD use was associated with therapeutic cannabis motives, suggesting potential for harm reduction by substituting high-THC products with CBD, according to the Europen Web Survey on Drugs.

Portugal cannabis paradox: Global export leader faces domestic crackdowns

Portuguese police conducted a major operation, “Erva Daninha” seizing seven tons of cannabis and arresting five individuals linked to a drug trafficking gang operating under the umbrella of licensed medical companies such as Cannaforest.

• As a result, Infarmed (National Authority for Medicament and Health Products) has implemented stricter requirements for medicinal cannabis import/export, raising concerns about increased processing times for companies.
  • Industry representatives suggest creating a list of verified international suppliers to streamline import/export processes and maintain efficiency.
• Aldo Vidinha resigned as CEO and shareholder of Stepscience amid legal issues and ongoing developments in the medicinal cannabis sector.
• Concerns arise about potential supply chain disruptions for patients due to regulatory crackdowns following the police bust, export permit approvals are facing increasing delays.

Portugal is the largest exporter of medicinal cannabis in Europe, and the second largest globally, with over 50 licensed companies and expected exports of 32 tonnes. Consumption remains low, with most cannabis products exported due to limited prescriptions and access for patients.

• Canna.biz achieves EU-GMP certification, utilizes high-density organic cultivation, and plans to expand processing and market reach in Europe.
• Challenges in obtaining medicinal cannabis in pharmacies; need for better information for patients and pharmacists emphasized by Anaísa Silva. Pharmacists are encouraged to seek updated information on medicinal cannabis to better assist patients who are dealing with stock issues and confusion.

 Portocanna’s CannValue project aims to develop five new medicinal cannabis products in three years, enhancing extraction processes sustainably.

• A study in collaboration with Somaì optimised extraction and purification processes to enhance sensory and therapeutic quality of full-spectrum cannabis extracts for medicinal use.

Netherland prioritises domestic patients in Cannabis policy shift, ending export licenses by 2026

Tender for medicinal cannabis licenses halted; supply to foreign parties ending by 2026; The Office of Medicinal Cannabis focusing solely on Dutch patients’ needs. Policy changes planned for 2027.

• Current grower Bedrocan and others withdrew from the tender due to changed policy intentions regarding cannabis supply.
• House of Representatives postpones cannabis experiment consideration to a future cabinet due to its controversial nature following cabinet collapse.

Inter-canopy lighting improves cannabis yield quality and energy efficiency, achieving higher quality buds while reducing energy costs by 50% compared to traditional top-ligthing methods.

• Research indicates cannabis innovation can benefit other crops, enhancing consistency and efficiency in agricultural practices.

 Growery officially starts cannabis production, meeting deadlines and supported by Essence Investment, alongside Linsboer and Legacy Brands.

Brazil’s National Health Agency reviews import procedures amid CBD price compression

RDC No. 327 (12/9/2019) establishes procedures for granting Health Authorization for manufacturing and importing of Cannabis products for medicinal purposes. This proposal aims to improve the current regulatory framework to ensure the continued availability of quality Cannabis products in the Brazilian market.

• A decree in Santa Catarina limits cannabis medicine supply to Anvisa-approved labs, excluding local producers and increasing costs for patients, amid local associations’ criticism.
• Paraíba Court upheld Abrace Esperança’s board, ensuring their stability and the right to a full defense amid ongoing investigations.

Medical CBD giant Prati-Donaduzzi reduces cannabidiol prices by up to 40%, effective July 1, 2025, to improve patient access to treatment in three concentrations: 200 mg, 50 mg, and 20 mg.

 Ciatox Unicamp in Campinas evaluates the composition of Cannabis oils implementing scientific methodologies to evaluate oils submitted by associations and patients who are authorised to import or produce these medicines.

Poland’s medical cannabis landscape rebounds with new product launches and renewed demand

After taking a significant 55% hit due to telemedicine ban last November, the medical market is now rebounding thanks to hybrid clinic models: medical cannabis prescriptions climbed back up 33% in March to 44 thousand.

• Aurora registers new cannabis varieties Sourdough and Farm Gas; delivery expected in July and August 2025, respectively.
• Shiraz, the official distributor of Tilray in Poland, announced that at the beginning of the week patients will be able to buy its two new varieties, Purps and Island Sweet Skunk in the Polish pharmaceutical market
• S-Lab also introduces new medical marijuana varieties in pharmacies; Headband, Sweet Berry Kush, Northen Berry, Purple Octane, Mimosa, Frosted Cherry Cookies and Biscuit Runtz.
• Spectrum Therapeutics launches Deep Breath, a high-THC Sativa strain, available in pharmacies after June 17, 2025.
• Cosma S.A. signed a strategic agreement with CanPoland S.A. for several years. New Gorilla Girl strain from Cosma SA features improved quality, refreshed packaging, and lower prices.
• Synoptis Pharma launched two new medical herb varieties produced by Tilray, Island Sweet Skunk and Beach Crasher, both with 22% THC content.

Israel strengthens leadership in global cannabis industry with continued innovation and market expansion

First debate on medical cannabis law scheduled; aims to allow private doctors to issue prescriptions amid Knesset dissolution concerns.

• The Prime Minister’s legal advisor definitively determines that Finance Minister Bezalel Smotrich was fully entitled to veto Economy Minister Nir Barkat’s decision to impose a 165% tax on medical cannabis imports from Canada.
• Medical cannabis vaporizer pens are expected to arrive in pharmacies for the first time; ground cannabis returns to the market.
• Three medical cannabis products banned due to pesticide residues; concerns raised about quality control at the David and Goliath plant.
• Yuval Landschaft, director of the Medical Cannabis Unit, is leaving after 12 years amid controversy and fatigue with the position.

Canndoc sets new record price for medical cannabis at NIS 479 per pack, raising concerns among patients and industry experts.

• Cronos is on track to be the first to launch medical cannabis vaporizer pens in Israel, as early as early 2026.
• Innocan Pharma reports 15% revenue growth, advances CBD technology, and receives FDA fee waiver for veterinary product LPT-CBD.

Italy grants Tilray first authorization to distribute medical cannabis flower, expanding therapeutic access

Patients will present demands for cannabis reform at the Chamber of Deputies on July 14, 2025, demanding urgent updates to the Lorenzin Decree and ensuring free access to medical cannabis for epilepsy patients.

 Tilray’s wholly owned subsidiary, FL Group, has received official authorization from the Ministero della Salute (Italian Ministry of Health) to import and distribute proprietary Tilray Medical-branded medical cannabis flower for therapeutic use.

• Three new Tilray Medical cannabis flower varieties approved for distribution through pharmacies across Italy.
• Tilray continues to lead the European medical cannabis market with operations in multiple countries, offering EU-GMP certified products.

New Zealand is announcing the world’s largest organic medical cannabis deal

Regulatory hurdles and stigma hinder the growth of New Zealand’s medical cannabis industry, impacting patient access and company viability, as companies like Cannasouth, Aether Pacific Pharmaceuticals and Greenfern faced financial difficulties.

Puro signed the largest organic medical cannabis export agreement ever with IPS Pharma, valued at £7 million. The deal improves access to high-quality medical cannabis for UK and European patients, meeting strict standards, and was made possible by New Zealand’s regulatory reforms.

• Helius Therapeutics, Green Leaf Group, and Elysian Group propose merger to form Helius Health, aiming to lower costs, simplify patient access and enhance product delivery in New Zealand’s cannabis industry.
• Zoë Reece, founder of Ora Pharm, leads a Kiwi trade mission to expand medicinal cannabis exports in Europe, focusing on cultivation and clinical trials.

Women are less likely than men to get a prescription for medicinal cannabis, and they tend not to disclose their use out of fear of societal rejection, turning to illicit markets.

Argentina faces regulatory hurdles in cannabis market while Brazil sets path for September 2025 framework

A presidential decree downgrades several agricultural and statistical agencies, including INTA, INASE, and the cannabis agency ARICCAME, potentially leading to significant public sector layoffs and the sale of properties owned by these agencies. Cannabis flowers and biomass will be regulated by the ANMAT (health regulator); hemp (without flowers) to Ministry of Economy as industrial crop.

• The Argentine government has implemented modifications to medicinal cannabis regulations aimed at facilitating access while affecting both personal use and organizational cultivation practices.
• Argentina’s cannabis regulatory landscape worsened with INASE blocking registrations, leaving operators in limbo despite an announced 60-day extension lacking formal implementation.

 GEN Foundation has achieved a milestone in national agricultural production, creating the country’s first edible hemp oil. Production is currently on an experimental scale, and the organization is looking forward to commercialization.

Preclinical evaluation of high-CBD medicinal cannabis anti-tumor properties on human cervical cancer cells; demonstrates anti-tumor activity against cervical cancer cells.

Spain’s cannabis market momentum grows despite legal barriers

Madrid regional president Ayuso’s administration is pushing for cannabis consumers to report illegal activities related to cannabis use and distribution.

• Meanwhile, the draft royal decree has been published in the website of the Health ministry after consultation with the EU—publication in the official law registry expected in the next weeks.

Industrial hemp cultivation in Catalonia has declined due to legal uncertainties and accusations of drug trafficking against farmers; in 2019, over 200 hectares of hemp were cultivated, but by 2023, official statistics reported zero hectares.

• Votum.World raised €550,000 in funding, with a pre-money valuation of €2.7 million, the funding will accelerate product development, team expansion, and internationalization efforts. The company achieved €229,200 revenue in 2024, with a 6% increase in profitability.
• Herbolario Navarro’s turnover reached €50 million, plans 100 stores by 2027, and invested €3 million in expansion projects. The eco-friendly and natural health chain Herbolario Navarro increased its turnover by 19% in 2024, reaching €50 million for the first time

Thailand bans recreational cannabis, restricts sales to medical use only

Thailand bans cannabis sales without prescriptions, reclassifying cannabis buds as a controlled herb amid public backlash and rising addiction concerns.

• The country has reclassified cannabis buds as a controlled herb for medical use only, immediately prohibiting advertising, sales, and recreational use.
• Cannabis advocates have expressed disappointment after learning about a new Public Health Ministry initiative that will require cannabis users to have medical certificates, to ensure that the plant is used for medical purposes only.
• Cannabis flower sales restricted to 30 grams per month with valid prescriptions from certified healthcare professionals, per new regulations.
• Up to 12,000 existing cannabis flower retailers may be forced to shut down as new rules will require specific medical professionals to be on-site.

 Squirrel Tail cannabis extract shows potential in inhibiting cholangiocarcinoma cell growth and inducing apoptosis through specific protein expression.

Morocco sets rules for regulated cultivation of cannabis for medical, pharmaceutical and industrial use

 Morocco advanced its legal cannabis industry; Mohammed VI Polytechnic University (UM6P) and the National Agency for the Regulation of Cannabis Activities (ANRAC) signed a framework agreement. This partnership aims to boost scientific research on therapeutic cannabis, with a specific focus on the local “Beldia” strain.

• Morocco also established regulations for medical cannabis cultivation, ensuring strict compliance and oversight for authorized agricultural cooperatives. The country published decree n°2.24.130 regulating medical cannabis cultivation and defining conditions for authorized agricultural cooperatives. Recreational cannabis cultivation remains prohibited.

Morocco legalized cannabis cultivation for medical use, producing its first legal crop in 2023 amidst evolving global cannabis regulations.

• It became the first country to produce legal cannabis from previously illegal hashish cultivation in 2023. Legalization of cannabis cultivation for medical, cosmetic, and industrial purposes occurred in Morocco on May 26, 2021.

Czech Republic regulated cannabis markets show reduced arrests

Stanovisko Rodin disputes the Supreme State Prosecutor’s claims about cannabis possession laws, clarifying legislative intent and legal definitions. Emphasis on the need for law enforcement to adapt to changes in cannabis possession laws and avoid misuse of charges.

Familiar cannabis clinic launches innovative patient-centered care in Klánovice. The clinic operates online, spesialised in neurology, orthopedics, and physiotherapy.

• Czech decriminalisation paves way for market opportunities, authorising cultivation of three cannabis plants and therapeutic use of psilocybin.

Regulated cannabis markets also demonstrate increased adult consumption, and higher healthcare utilization, though outcomes vary significantly across different jurisdictions.

• Frontiers in plant science has established a protocol for Cannabis sativa protoplast isolation and cultivation, revealing robust antioxidant responses and regenerative potential.

Austrian CBD shops face legal challenges as the country establishes itself as a European hub for cannabis genetics

Legal uncertainty continues for CBD flower sales in Austria, despite a favorable opinion from lawyer Prof. Heinz Mayer: Ministry of Finance maintains CBD sales in shops are illegal, citing violations of the Tobacco Monopoly Act. Expected sales of CBD flowers in tobacco shops by July.

 Alpine Biolabs partners with Umami Seed Co to introduce exclusive cannabis cultivars in Europe through their facilities. The collaboration offers licensed cultivators pathogen-free, production-ready clones and tissue culture mother plants on-demand.

Switzerland cannabis model shows early promise

 Switzerland moves towards decriminalization of cannabis, new draft law paves the way for regulated access, envisaging a strictly regulated approach for adults, without promoting consumption.

• Patients say swiss cannabis law must address ‘unsatisfactory’ medical access ahead of further reform

 Swisscann is raising capital with a target of £500,004 and has raised £450,536 from 162 investors. The company focuses on producing and distributing premium medical cannabis, with all products sold out until 2026.

• Cronos Group Inc. announced that it is expanding distribution with its Peace Naturals medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG, a Swiss-based company specialised in the supply and distribution of medical cannabis and health care training.

Legal cannabis sales in pharmacies reduced abuse symptoms among users, particularly benefiting high-risk groups, according to a Swiss study based on data from ‘Weedcare’, the recreational pilot project taking place in Basel-stadt.

• Participants purchasing cannabis from pharmacies reported decreased problematic use, while control group usage remained relatively unchanged.

Costa Rica medical cannabis is now available with prescription

Strict regulations limit sales to pharmacies. Criticism arises over restrictive regulations favoring pharmacies, creating an oligopoly and limiting competition in the market

• Costa Rica mandates medical prescriptions for cannabis products, effective June 22, ensuring safe and controlled usage through pharmacies.
• The College of Pharmacists reminds everyone of the importance of a prescription for medicinal cannabis products.

 GrowGen has launched its proprietary brands in Costa Rica, whose government has issued over 50 licenses for hemp and cannabis production during the past year. The country’s favorable growing conditions and developing export infrastructure make it a key growth market in Central America.

Greece’s European cannabis market goals

 Grecan has obtained its EU-GMP certification and it now aims to establish Greece as a key player in the European cannabis market through local production and quality focus.

• The company emphasizes sustainability, using solar energy and innovative processing methods to meet strict microbial standards. Grecan plans to expand into extracts and distillates while seeking joint ventures to cater to market demands effectively.

In a decisive move, the Greek Health Minister, Adonis Georgiadis, announced that Hexahydrocannabinol (HHC) and its derivatives are now classified as narcotics.

Belgium refunds CBD for children with severe epilepsy

Since May 1, CBD is reimbursed in Belgium for children with severe epilepsy, such as Dravet syndrome. A certificate from a qualified specialist is required and applies to children aged 2 years and older. The program will have an estimated annual cost of €1.5 milions, which Minister Vandenbroucke views as a responsible investment.

• Lillo firefighters are the first in Flandes to use hemp to decontaminate soil polluted with PFAS. The technique is being applied in collaboration with Ghent University and the company Phytolutions.

Belgian startup CBX Medical, has partnered with the CHC to plant three hectares of cannabis in a field adjacent to its clinic in Hermalle. This innovative initiative aims to combine medical research with the benefits of this plant.

Finland sees increased medical cannabis use

A massive operation involving Finland ends in Albanian criminal network leaders arrested

More patients using non-medical grade cannabis for self-medication due to access issues.

• Attitudes toward cannabis shifted: 24% support legal access for any reason, up from 10% in 2010. Medical users are often older, less educated, and more likely to use cannabis for self-medication than recreational users.

South Africa cannabis industry holds great promise

South Africa’s medical cannabis and hemp sector is on the verge of transformation, but industry leaders say it will take robust education, policy reform and home-grown innovation to realise its full potential.

• Medicinal cannabis cultivation is legal in South Africa under strict regulations, promoting public education on its benefits. South African universities are investing in cannabis research, emphasizing collaboration with private companies for meaningful advancements.
• The Department of Trade, Industry and Competition is preparing to resubmit the National Cannabis Master Plan to National Economic Development and Labour Council which will includes provision for the legal trade in cannabis
  • DTIC unveils its route markers to navigate South Africa towards the legal trade in cannabis.

Turkey expands cannabis production and moves toward medicinal use

Türkiye has significantly expanded its industrial cannabis production over the past five years and is now poised to harness the plant’s medicinal benefits through a new health care regulation, aligning with global advancements in the field.

• Cannabis production increased significantly, from 280 tons in 2020 to over 1,700 tons in 2024, following renewed interest. Licensed sales of cannabis products will be limited to pharmacies, ensuring product control and safety.

Mexico issues first medical cannabis patent

 Innocan Pharma granted its first patent in Mexico for a proprietary cannabis-based topical pain relief formulation.

• The patent covers a groundbreaking formulation comprising the unique blending of cannabidiol with minerals to deliver fast-acting, targeted pain relief.

Indonesia’s Narcotics Agency to explore legalization of Medical Cannabis

Indonesia’s National Narcotics Agency plans a study on medical cannabis use, responding to public pressure and a court mandate.

• The research aims to explore cannabis’s medical benefits, following two Constitutional Court decisions urging government action. Indonesia maintains strict drug laws, but this initiative signals potential regulatory changes if scientific findings support medical cannabis use.

Moldova sows its first industrial hemp crops

Farmers must apply to grow hemp and register harvesting activities, using only approved plant varieties. Ion Sahanovschi is among the first farmers to cultivate hemp, starting with 8 hectares in Criuleni district.

• New regulations permit hemp cultivation strictly for fiber and seed, with restrictions on flowers and cannabinoids like CBD. Prime Minister Dorin Recean sees hemp cultivation as a significant opportunity for Moldova’s rural economy and agricultural development.

Panama finally approves the regulation that activates the medicinal use of cannabis

Panama’s Executive Decree No. 6 establishes regulations for the therapeutic use of cannabis after years of waiting. The decree establishes production, importation, marketing, and prescription protocols for medical cannabis.

• Companies must meet specific requirements to operate, including maintaining secure facilities and employing trained personnel, with regulatory oversight to ensure compliance.

Paraguay eradicates criminal cultivation in natural reserve

“Nueva Alianza 50” operation destroyed 816 tons of marijuana in Paraguay, arresting 62 individuals and impacting drug trafficking significantly.

• The operation targeted illegal cannabis cultivation in Morombí nature reserve, causing over $24.5 million in losses to criminal organizations, and highlighting coperation between Parguay and Brazil in combating transnational crime.

North Macedonia cannabis market in transition

 Endo Canna, a Polish-funded company, focused on small batch production, grows high-quality cannabis in North Macedonia, targeting the German medical market first.

• Ohrid organics, a subsidiary of Hydrogen Utopia International PLC (HUI), has entered into a significant sales agreement providing for the supply of up to €4.5 million in GACP-compliant cannabis products over the next 12 months, establishing a stable revenue foundation for the company’s North Macedonian operations.

Colombia’s National University offers a cannabis flower production education

Course includes lab work on stability tests and practical training in a greenhouse for low-cost cannabis production, with focus on quality management, public health, and legal avenues for cannabis legalization in rural areas emphasized throughout the course.

Medcann Pharma marks a milestone in the cannabis industry with exports of micro-propagated genetics to Europe, where Spain and Portugal were the first to receive the clones.

Uganda greenlights its first industrial hemp permit

Ugandan officials appear ready to issue the country’s first-ever industrial hemp farming permit, a landmark move that could jumpstart a national supply chain.

• Uganda set to issue its first industrial hemp farming permit to Mwamic General Enterprises SMC Ltd for economic development.
  • The initiative aims for massive seed production and involves 45,000 veterans, with 450 already participating in organized groups. An Industrial Hemp Day event is planned for July 9 to raise awareness and support for the hemp industry.

Ireland’s brand Hemp Heros expands into US market

David Hartigan established Hemp Heros to produce pet CBD products, prioritizing US manufacturing for market expansion and competitive advantage.

• The company offers a range of ten pet-focused CBD products, addressing various health issues and aiming for US market growth.

Chile cannabis research and clinical trials are increasing

Study investigates brain function changes in 20 adult marijuana users after 6 months of abstinence.

• Preliminary results show some improvement in working memory and attention after abstinence in three subjects. NeuroSPECT reveals disorganized hypoperfusion in cognitive areas, with two participants re-evaluated showing some improvement post-abstinence.

Ecuador has more than 2,300 hectares of legal hemp and non-psychoactive cannabis cultivation

Ecuador is making progress in cannabis regulation with more than 300 active licenses and a technical manual that supports the growth of the hemp and non-psychoactive cannabis industry.

Peru medicinal cannabis industry grows in silence

Perú approved regulations for medicinal cannabis in 2017, promoting safe access and growth in the market, despite challenges in patient registration.

• The legal cannabis market is projected to grow significantly, with estimated annual revenues between US$ 8 million and 5 million for 2025. Key challenges include low patient registration and bureaucratic hurdles, impacting safe access and market growth for cannabis products.